US 12370163
Levodopa dosing regimen
granted A61KA61K31/198A61K9/4825
Quick answer
US patent 12370163 (Levodopa dosing regimen) held by AMNEAL PHARMACEUTICALS LLC expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AMNEAL PHARMACEUTICALS LLC
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/198, A61K9/4825, A61K9/5005, A61K9/5026